Isabel Jimenez

Isabel started at Asabys in 2022 as an Associate. She is responsible for evaluating novel opportunities from a scientific and strategic perspective focused on the biotech sector.

Isabel joined Asabys after working at Ysios Capital where she screened and analyzed deal flow while conducting due diligence on companies developing novel therapeutic approaches. Previously, Isabel spent 7y+ as a researcher in immunology and oncology. She completed her doctoral thesis at Vall d’Hebron Institute of Oncology (VHIO) in hemato-oncology.

Isabel earned a Ph.D. in Medicine from the University Autònoma de Barcelona (UAB), a MSc in Advanced Immunology from the University of Barcelona (UB), and a BSc in Biochemistry. She also holds an Executive MBA from ESADE Business School.